Great News. Share price is absurdly low -- that ideal time to buy, buy, buy the company's shares. HIV and HEP C has been cured. Company's pipeline in Oncology, NASH and other debilitating conditions/diseases if formidable. Future is very bright and the shares are being given away at a 5x FPE. Time to load up and accelerate the remaining buyback plan.
GILD shares are wonderful buying opportunity. Company's buyback plan is going to double the share price as QTR earnings keep coming in strong and stronger. HIV and HEP genotypes are seeing huge additions to the Patient pools. This is a lifetime opportunity to get a 2 and 3 bagger from here.